Comparing the levels of trace elements in patients with diabetic nephropathy and healthy individuals

Nephro-Urology Monthly

Volumn 7, Issue 4, 2015, Pages

  Makhlough, Atieh ^a   Makhlough, Marjan ^b   Shokrzadeh, Mohammad ^c   Mohammadian, Mozhdeh ^b   Sedighi, Omid ^b   Faghihan, Mansooreh ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atomic absorption; Chromium; Copper; Diabetic nephropathies; Zinc

Indexed keywords

CHROMIUM; COPPER ION; DRINKING WATER; ZINC ION;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHROMIUM BLOOD LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DESCRIPTIVE RESEARCH; DIABETIC NEPHROPATHY; HUMAN; INFERENTIAL STATISTICS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PATHOPHYSIOLOGY; URINALYSIS; WATER SUPPLY; ZINC BLOOD LEVEL;

EID: 84940913342     PISSN: 22517006     EISSN: 22517014     Source Type: Journal    
DOI: 10.5812/numonthly.28576     Document Type: Article

References (36)

1. Aryangat AV, Gerich JE. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag. 2010;6:145-55.
2. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62-9.
3. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18(10):2644-8.
4. Li Y, Burrows NR, Gregg EW, Albright A, Geiss LS. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988- 2008. Diabetes Care. 2012;35(2):273-7.
5. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948-59.
6. Salem M, Kholoussi S, Kholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellenic Med. 2011;28(Suppl 1):83-8.
7. Mishra J, Carpenter S, Singh S. Low serum zinc levels in an endemic area of visceral leishmaniasis in Bihar, India. Indian J Med Res. 2010;131:793-8.
8. Josko O. Copper and zinc, biological role and significance of copper/zinc imbalance. Journal of Clinical Toxicology. 2011.
9. El Missiry M, Hamed Hussein M, Khalid S, Yaqub N, Khan S, Itrat F, et al. Assessment of serum zinc levels of patients with thalassemia compared to their siblings. Anemia. 2014;2014:125452.
10. Charney P, Escott-Stump S, Mahan LK. Nutrition diagnosis and intervention. Krause's Food and Nutrition Therapy. 12th ed. St Louis, MO: Saunders Elsevier. 2008:454-69.
11. Thomas B, Kumari S, Ramitha K, Ashwini Kumari MB. Comparative evaluation of micronutrient status in the serum of diabetes mellitus patients and healthy individuals with periodontitis. J Indian Soc Periodontol. 2010;14(1):46-9.
12. Li B, Tan Y, Sun W, Fu Y, Miao L, Cai L. The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicol Mech Methods. 2013;23(1):27-33.
13. Marreiro DN, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SM. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112(2):109-18.
14. Kim J, Lee S. Effect of zinc supplementation on insulin resistance and metabolic risk factors in obese Korean women. Nutr Res Pract. 2012;6(3):221-5.
15. Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695-703.
16. Pizzimenti S, Ciamporcero E, Daga M, Pettazzoni P, Arcaro A, Cetrangolo G, et al. Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front Physiol. 2013;4:242.
17. Miao X, Sun W, Miao L, Fu Y, Wang Y, Su G, et al. Zinc and diabetic retinopathy. Journal of diabetes research. 2013;2013.
18. Prasad AS. Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health. Front Nutr. 2014;1:14.
19. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr. 2010;91(6):1634-41.
20. Song Y, Leonard SW, Traber MG, Ho E. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats. J Nutr. 2009;139(9):1626-31.
21. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058-70.
22. Puri M, Gujral U, Nayyar SB. Comparative study of serum zinc, magnesium and copper levels among patients of type 2 diabetes mellitus with and without microangiopathic complications. INNOVATIVE JOURNAL OF MEDICAL AND HEALTH SCIENCE. 2013;3(6).
23. Eaton JW, Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem. 2002;234-235(1-2):135-42.
24. Ahmadpour S, Sadeghi YOUSEF, Hami J, Haghir H. Effects of insulin and ascorbic acid therapy on plasma cu level in streptozotocin-induced diabetic rats. Journal of Birjand University of Medical Sciences. 2008;15(3):26-31.
25. Sakamoto K, Brownlee M. Type 1 Diabetes. Springer; 2003. pp. 375-92.
26. Guimaraes MM, Martins Silva Carvalho AC, Silva MS. Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes. J Am Coll Nutr. 2013;32(4):243-50.
27. Jain SK, Rains JL, Croad JL. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med. 2007;43(8):1124-31.
28. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27(11):2741-51.
29. Khan AR, Awan FR. Metals in the pathogenesis of type 2 diabetes. J Diabetes Metab Disord. 2014;13(1):16.
30. Jamshidi F, Tasallli E, Heshmat R, Kimiagar M, Larijanio B. Evaluation of Mg, Zn and Cu serum levels in Diabetic and nondiabetic persons and its relationship with anemic situation in food rejims. Diabetes and Lipid J.;9(3):249-59.
31. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008;122(1):1-18.
32. Nasli-Esfahani E, Faridbod F, Larijani B, Ganjali MR, Norouzi P. Trace element analysis of hair, nail, serum and urine of diabetes mellitus patients by inductively coupled plasma atomic emission spectroscopy. Journal of Diabetes & Metabolic Disorders. 2011;10(1):5.
33. Adewumi MT, Njoku CH, Saidu Y, Abubakar MK, Shehu RA, Bilbis LS. Serum chromium, copper, and manganese levels of diabetic subjects in Katsina, Nigeria. Asian J. Biochem. 2007;2:284-8.
34. SABOURI SOMAYEH, Mohtadinia J, ALIASGARZADEH A, NOUMI G, YOUSEFIRAD E. The relationship between serum level of chromium and serum malondialdehyde in patients with type II diabetes. 2010.
35. Talaei A, Jabari S, Bigdeli MH, Farahani H, Siavash M. Correlation between microalbuminuria and urinary copper in type two diabetic patients. Indian J Endocrinol Metab. 2011;15(4):316-9.
36. Al-Timimi DJ, Sulieman DM, Hussen KR. Zinc status in type 2 diabetic patients: relation to the progression of diabetic nephropathy. J Clin Diagn Res. 2014;8(11):CC04-8.